Growing evidence links even low-level PFAS exposure to endocrine disruption, with a new study identifying n-PFOS as a leading driver of risk among women.
Infertility treatments have traditionally placed the burden on women. Antibody-based therapies could redistribute the responsibility and bring new hope for couples.
The Medicine Maker
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
As Trump’s health officials push personal responsibility, critics warn their rhetoric blames patients, shapes policy, and risks deepening health inequalities.
A growing number of young Americans lose affordable health insurance at age 26, facing complex Affordable Care Act marketplaces, rising costs, and limited coverage options.